APA (7th ed.) Citation

Petrie, M. C., Udell, J. A., Anker, S. D., Harrington, J., Jones, W. S., Mattheus, M., . . . Butler, J. (2024). Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trial. European journal of heart failure, 27(3), . https://doi.org/10.1002/ejhf.3548

Chicago Style (17th ed.) Citation

Petrie, Mark C., et al. "Empagliflozin in Acute Myocardial Infarction in Patients with and Without Type 2 Diabetes: A Pre-specified Analysis of the EMPACT-MI Trial." European Journal of Heart Failure 27, no. 3 (2024). https://doi.org/10.1002/ejhf.3548.

MLA (9th ed.) Citation

Petrie, Mark C., et al. "Empagliflozin in Acute Myocardial Infarction in Patients with and Without Type 2 Diabetes: A Pre-specified Analysis of the EMPACT-MI Trial." European Journal of Heart Failure, vol. 27, no. 3, 2024, https://doi.org/10.1002/ejhf.3548.